Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
288 participants
OBSERVATIONAL
2020-02-01
2021-07-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Repeatability of Electroretinogram and Visual Evoked Potential
NCT05334875
Causes of Visual Impairment Among Patients Applying for the Visually Disability Certification
NCT06518148
Optical Coherence Tomography Angiography in Myopic Patients
NCT04135209
Optical Coherence Tomography Measurements in Eyes With Band Atrophy
NCT00395122
Correlation Between OCT and Mf-ERG Findings With BCVA in Patients With Macular Dystrophy
NCT07171541
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard vision chart.
Best corrected visual acuity measured by standard chart projector.
Distant best corrected visual acuity assessment
Measuring distant visual acuity on snellen's chart using two methods and results were converted to equivalent logarithm of minimum angle of resolution to compare accuracy of mobile based chart to the standard vision chart.
Mobile based vision chart.
Best corrected visual acuity measured by mobile based chart with screen mirroring over 24 inch monitor.
Distant best corrected visual acuity assessment
Measuring distant visual acuity on snellen's chart using two methods and results were converted to equivalent logarithm of minimum angle of resolution to compare accuracy of mobile based chart to the standard vision chart.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Distant best corrected visual acuity assessment
Measuring distant visual acuity on snellen's chart using two methods and results were converted to equivalent logarithm of minimum angle of resolution to compare accuracy of mobile based chart to the standard vision chart.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects that their best corrected visual acuity was ranged from 0.1 to 1.0 in decimal form measured on snellen's chart.
Exclusion Criteria
* Subjects that their best corrected visual acuity is less than 0.1 in decimal form by the standard chart projector.
4 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Benha University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Abdelshafy
Lecturer of Ophthalmology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed A Abdelshafy, MD
Role: STUDY_CHAIR
Benha University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Al-Nil Hospital
Banhā, QA, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC-15-2-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.